Industry: Chemical & Material
Published Date: 2026-07-14
Pages: 129 Pages
Report ld: 6895215
Request Sample
Customized Report
The global market for Anthelmintic Fenbendazole was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Fenbendazole is a drug substance classified under the category ‘Anthelmintic Agent’ (for veterinary use) .It is used in the treatment & control of fluke infections of the digestive system caused by roundworms , tapeworms , hookworms , lungworms which are generally found in Cats , Sheeps, Goats ,Pet birds , Pigeons. Hence this drug is an effective de-wormer in animals.
The North American market for Anthelmintic Fenbendazole was valued at US$ million in 2025 and is projected to reach US$ million by 2032, at a CAGR of % from 2026 to 2032.
The Asia-Pacific market for Anthelmintic Fenbendazole was valued at $ million in 2025 and is projected to climb to US$ million by 2032, at a CAGR of % from 2026 to 2032.
The European market for Anthelmintic Fenbendazole was valued at $ million in 2025 and is projected to total US$ million by 2032, at a CAGR of % from 2026 to 2032.
The global key companies in the Anthelmintic Fenbendazole market include Alivira Animal Health, Vaishali Pharma, Bazayan & Co, Rochem International, Jiangsu Baozong & Baoda Pharmachem, Shanxi Hanjiang pharmaceutical, Lasa Supergenerics Limited, Procyon Life Sciences, etc. In 2025, the five largest players accounted for approximately % of revenue.
This report provides a comprehensive view of the global market for Anthelmintic Fenbendazole, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The Anthelmintic Fenbendazole market size, estimations, and forecasts are presented in terms of sales volume (Ton) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Anthelmintic Fenbendazole.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.
Chapter 2: Provides a detailed analysis of the Anthelmintic Fenbendazole manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Anthelmintic Fenbendazole sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Anthelmintic Fenbendazole sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.
Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Anthelmintic Fenbendazole Product Introduction
1.2 Global Anthelmintic Fenbendazole Market Size Forecast
1.2.1 Global Anthelmintic Fenbendazole Sales Value (2021–2032)
1.2.2 Global Anthelmintic Fenbendazole Sales Volume (2021–2032)
1.2.3 Global Anthelmintic Fenbendazole Sales Price (2021–2032)
1.3 Anthelmintic Fenbendazole Market Trends & Drivers
1.3.1 Anthelmintic Fenbendazole Industry Trends
1.3.2 Anthelmintic Fenbendazole Market Drivers & Opportunities
1.3.3 Anthelmintic Fenbendazole Market Challenges
1.3.4 Anthelmintic Fenbendazole Market Restraints
1.3.5 Impact of U.S. Tariffs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Anthelmintic Fenbendazole Players Revenue Ranking (2025)
2.2 Global Anthelmintic Fenbendazole Revenue by Company (2021–2026)
2.3 Global Anthelmintic Fenbendazole Sales Volume Ranking of Players (2025)
2.4 Global Anthelmintic Fenbendazole Sales Volume by Company (2021–2026)
2.5 Global Anthelmintic Fenbendazole Average Price by Company (2021–2026)
2.6 Key Manufacturers Anthelmintic Fenbendazole Manufacturing Base and Headquarters
2.7 Key Manufacturers Anthelmintic Fenbendazole Product Offerings
2.8 Key Manufacturers Start of Mass Production of Anthelmintic Fenbendazole
2.9 Anthelmintic Fenbendazole Market Competitive Analysis
2.9.1 Anthelmintic Fenbendazole Market Concentration Rate (2021–2026)
2.9.2 Global 5 and 10 Largest Manufacturers by Anthelmintic Fenbendazole Revenue in 2025
2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Anthelmintic Fenbendazole revenue, 2025
2.10 Mergers & Acquisitions and Expansion
3 Segmentation Anthelmintic Fenbendazole Market Classification
3.1 Introduction by Type
3.1.1 ≥98%
3.1.2 ≥99%
3.1.3 Other
3.1.4 Global Anthelmintic Fenbendazole Sales Value by Type
3.1.4.1 Global Anthelmintic Fenbendazole Sales Value by Type (2021 vs 2025 vs 2032)
3.1.4.2 Global Anthelmintic Fenbendazole Sales Value, by Type (2021–2032)
3.1.4.3 Global Anthelmintic Fenbendazole Sales Value, by Type (%), 2021–2032
3.1.5 Global Anthelmintic Fenbendazole Sales Volume by Type
3.1.5.1 Global Anthelmintic Fenbendazole Sales Volume by Type (2021 vs 2025 vs 2032)
3.1.5.2 Global Anthelmintic Fenbendazole Sales Volume, by Type (2021–2032)
3.1.5.3 Global Anthelmintic Fenbendazole Sales Volume, by Type (%), 2021–2032
3.1.6 Global Anthelmintic Fenbendazole Average Price by Type (2021–2032)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Fenbendazole Granule
4.1.2 Fenbendazole Powder
4.1.3 Fenbenazole Tablet
4.1.4 Other
4.2 Global Anthelmintic Fenbendazole Sales Value by Application
4.2.1 Global Anthelmintic Fenbendazole Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global Anthelmintic Fenbendazole Sales Value, by Application (2021–2032)
4.2.3 Global Anthelmintic Fenbendazole Sales Value, by Application (%), 2021–2032
4.3 Global Anthelmintic Fenbendazole Sales Volume by Application
4.3.1 Global Anthelmintic Fenbendazole Sales Volume by Application (2021 vs 2025 vs 2032)
4.3.2 Global Anthelmintic Fenbendazole Sales Volume, by Application (2021–2032)
4.3.3 Global Anthelmintic Fenbendazole Sales Volume, by Application (%), 2021–2032
4.4 Global Anthelmintic Fenbendazole Average Price by Application (2021–2032)
5 Segmentation by Region
5.1 Global Anthelmintic Fenbendazole Sales Value by Region
5.1.1 Global Anthelmintic Fenbendazole Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global Anthelmintic Fenbendazole Sales Value by Region (2021–2026)
5.1.3 Global Anthelmintic Fenbendazole Sales Value by Region (2027–2032)
5.1.4 Global Anthelmintic Fenbendazole Sales Value by Region (%), 2021–2032
5.2 Global Anthelmintic Fenbendazole Sales Volume by Region
5.2.1 Global Anthelmintic Fenbendazole Sales Volume by Region: 2021 vs 2025 vs 2032
5.2.2 Global Anthelmintic Fenbendazole Sales Volume by Region (2021–2026)
5.2.3 Global Anthelmintic Fenbendazole Sales Volume by Region (2027–2032)
5.2.4 Global Anthelmintic Fenbendazole Sales Volume by Region (%), 2021–2032
5.3 Global Anthelmintic Fenbendazole Average Price by Region (2021–2032)
5.4 North America
5.4.1 North America Anthelmintic Fenbendazole Sales Value, 2021–2032
5.4.2 North America Anthelmintic Fenbendazole Sales Value by Country (%), 2025 vs 2032
5.5 Europe
5.5.1 Europe Anthelmintic Fenbendazole Sales Value, 2021–2032
5.5.2 Europe Anthelmintic Fenbendazole Sales Value by Country (%), 2025 vs 2032
5.6 Asia Pacific
5.6.1 Asia Pacific Anthelmintic Fenbendazole Sales Value, 2021–2032
5.6.2 Asia Pacific Anthelmintic Fenbendazole Sales Value by Region (%), 2025 vs 2032
5.7 South America
5.7.1 South America Anthelmintic Fenbendazole Sales Value, 2021–2032
5.7.2 South America Anthelmintic Fenbendazole Sales Value by Country (%), 2025 vs 2032
5.8 Middle East & Africa
5.8.1 Middle East & Africa Anthelmintic Fenbendazole Sales Value, 2021–2032
5.8.2 Middle East & Africa Anthelmintic Fenbendazole Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Anthelmintic Fenbendazole Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions Anthelmintic Fenbendazole Sales Value and Sales Volume
6.2.1 Key Countries/Regions Anthelmintic Fenbendazole Sales Value, 2021–2032
6.2.2 Key Countries/Regions Anthelmintic Fenbendazole Sales Volume, 2021–2032
6.3 United States
6.3.1 United States Anthelmintic Fenbendazole Sales Value, 2021–2032
6.3.2 United States Anthelmintic Fenbendazole Sales Value by Type (%), 2025 vs 2032
6.3.3 United States Anthelmintic Fenbendazole Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe Anthelmintic Fenbendazole Sales Value, 2021–2032
6.4.2 Europe Anthelmintic Fenbendazole Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe Anthelmintic Fenbendazole Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China Anthelmintic Fenbendazole Sales Value, 2021–2032
6.5.2 China Anthelmintic Fenbendazole Sales Value by Type (%), 2025 vs 2032
6.5.3 China Anthelmintic Fenbendazole Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan Anthelmintic Fenbendazole Sales Value, 2021–2032
6.6.2 Japan Anthelmintic Fenbendazole Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan Anthelmintic Fenbendazole Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea Anthelmintic Fenbendazole Sales Value, 2021–2032
6.7.2 South Korea Anthelmintic Fenbendazole Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea Anthelmintic Fenbendazole Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia Anthelmintic Fenbendazole Sales Value, 2021–2032
6.8.2 Southeast Asia Anthelmintic Fenbendazole Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia Anthelmintic Fenbendazole Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India Anthelmintic Fenbendazole Sales Value, 2021–2032
6.9.2 India Anthelmintic Fenbendazole Sales Value by Type (%), 2025 vs 2032
6.9.3 India Anthelmintic Fenbendazole Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 Alivira Animal Health
7.1.1 Alivira Animal Health Company Information
7.1.2 Alivira Animal Health Introduction and Business Overview
7.1.3 Alivira Animal Health Anthelmintic Fenbendazole Sales, Revenue, Price and Gross Margin (2021–2026)
7.1.4 Alivira Animal Health Anthelmintic Fenbendazole Product Offerings
7.1.5 Alivira Animal Health Recent Developments
7.2 Vaishali Pharma
7.2.1 Vaishali Pharma Company Information
7.2.2 Vaishali Pharma Introduction and Business Overview
7.2.3 Vaishali Pharma Anthelmintic Fenbendazole Sales, Revenue, Price and Gross Margin (2021–2026)
7.2.4 Vaishali Pharma Anthelmintic Fenbendazole Product Offerings
7.2.5 Vaishali Pharma Recent Developments
7.3 Bazayan & Co
7.3.1 Bazayan & Co Company Information
7.3.2 Bazayan & Co Introduction and Business Overview
7.3.3 Bazayan & Co Anthelmintic Fenbendazole Sales, Revenue, Price and Gross Margin (2021–2026)
7.3.4 Bazayan & Co Anthelmintic Fenbendazole Product Offerings
7.3.5 Bazayan & Co Recent Developments
7.4 Rochem International
7.4.1 Rochem International Company Information
7.4.2 Rochem International Introduction and Business Overview
7.4.3 Rochem International Anthelmintic Fenbendazole Sales, Revenue, Price and Gross Margin (2021–2026)
7.4.4 Rochem International Anthelmintic Fenbendazole Product Offerings
7.4.5 Rochem International Recent Developments
7.5 Jiangsu Baozong & Baoda Pharmachem
7.5.1 Jiangsu Baozong & Baoda Pharmachem Company Information
7.5.2 Jiangsu Baozong & Baoda Pharmachem Introduction and Business Overview
7.5.3 Jiangsu Baozong & Baoda Pharmachem Anthelmintic Fenbendazole Sales, Revenue, Price and Gross Margin (2021–2026)
7.5.4 Jiangsu Baozong & Baoda Pharmachem Anthelmintic Fenbendazole Product Offerings
7.5.5 Jiangsu Baozong & Baoda Pharmachem Recent Developments
7.6 Shanxi Hanjiang pharmaceutical
7.6.1 Shanxi Hanjiang pharmaceutical Company Information
7.6.2 Shanxi Hanjiang pharmaceutical Introduction and Business Overview
7.6.3 Shanxi Hanjiang pharmaceutical Anthelmintic Fenbendazole Sales, Revenue, Price and Gross Margin (2021–2026)
7.6.4 Shanxi Hanjiang pharmaceutical Anthelmintic Fenbendazole Product Offerings
7.6.5 Shanxi Hanjiang pharmaceutical Recent Developments
7.7 Lasa Supergenerics Limited
7.7.1 Lasa Supergenerics Limited Company Information
7.7.2 Lasa Supergenerics Limited Introduction and Business Overview
7.7.3 Lasa Supergenerics Limited Anthelmintic Fenbendazole Sales, Revenue, Price and Gross Margin (2021–2026)
7.7.4 Lasa Supergenerics Limited Anthelmintic Fenbendazole Product Offerings
7.7.5 Lasa Supergenerics Limited Recent Developments
7.8 Procyon Life Sciences
7.8.1 Procyon Life Sciences Company Information
7.8.2 Procyon Life Sciences Introduction and Business Overview
7.8.3 Procyon Life Sciences Anthelmintic Fenbendazole Sales, Revenue, Price and Gross Margin (2021–2026)
7.8.4 Procyon Life Sciences Anthelmintic Fenbendazole Product Offerings
7.8.5 Procyon Life Sciences Recent Developments
8 Industry Chain Analysis
8.1 Anthelmintic Fenbendazole Industrial Chain
8.2 Anthelmintic Fenbendazole Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customer Analysis)
8.5 Sales Model and Sales Channelss
8.5.1 Anthelmintic Fenbendazole Sales Model
8.5.2 Sales Channels
8.5.3 Anthelmintic Fenbendazole Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Anthelmintic Fenbendazole market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-21
Pages: 134
USD 2900.00
(Single User License)
The global Anthelmintic Fenbendazole market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-22
Pages: 142
USD 4900.00
(Single User License)
The global market for Anthelmintic Fenbendazole was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-15
Pages: 95
USD 3950.00
(Single User License)
The global market for Anthelmintic Fenbendazole was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-15
Pages: 91
USD 2900.00
(Single User License)
The global Anthelmintic Fenbendazole market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-15
Pages: 79
USD 4250.00
(Single User License)
Fenbendazole is a drug substance classified under the category ‘Anthelmintic Agent’ (for veterinary use) .It is used in the treatment & control of fluke infections of the digestive system caused by roundworms , tapeworms , hookworms , lungworms which are generally found in Cats , Sheeps, Goats ,Pet birds , Pigeons. Hence this drug is an effective de-wormer in animals.
Published Date: 2024-04-08
Pages: 91
USD 4900.00
(Single User License)
Fenbendazole is a drug substance classified under the category ‘Anthelmintic Agent’ (for veterinary use) .It is used in the treatment & control of fluke infections of the digestive system caused by roundworms , tapeworms , hookworms , lungworms which are generally found in Cats , Sheeps, Goats ,Pet birds , Pigeons. Hence this drug is an effective de-wormer in animals.
Published Date: 2024-02-22
Pages: 98
USD 3950.00
(Single User License)
Fenbendazole is a drug substance classified under the category ‘Anthelmintic Agent’ (for veterinary use) .It is used in the treatment & control of fluke infections of the digestive system caused by roundworms , tapeworms , hookworms , lungworms which are generally found in Cats , Sheeps, Goats ,Pet birds , Pigeons. Hence this drug is an effective de-wormer in animals.
Published Date: 2024-01-16
Pages: 91
USD 2900.00
(Single User License)
The global Anthelmintic Fenbendazole market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-21
Pages: 134
The global Anthelmintic Fenbendazole market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-22
Pages: 142
The global market for Anthelmintic Fenbendazole was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-15
Pages: 95
The global market for Anthelmintic Fenbendazole was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-15
Pages: 91
The global Anthelmintic Fenbendazole market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-15
Pages: 79
Fenbendazole is a drug substance classified under the category ‘Anthelmintic Agent’ (for veterinary use) .It is used in the treatment & control of fluke infections of the digestive system caused by roundworms , tapeworms , hookworms , lungworms which are generally found in Cats , Sheeps, Goats ,Pet birds , Pigeons. Hence this drug is an effective de-wormer in animals.
Published: 2024-04-08
Pages: 91
Fenbendazole is a drug substance classified under the category ‘Anthelmintic Agent’ (for veterinary use) .It is used in the treatment & control of fluke infections of the digestive system caused by roundworms , tapeworms , hookworms , lungworms which are generally found in Cats , Sheeps, Goats ,Pet birds , Pigeons. Hence this drug is an effective de-wormer in animals.
Published: 2024-02-22
Pages: 98
Fenbendazole is a drug substance classified under the category ‘Anthelmintic Agent’ (for veterinary use) .It is used in the treatment & control of fluke infections of the digestive system caused by roundworms , tapeworms , hookworms , lungworms which are generally found in Cats , Sheeps, Goats ,Pet birds , Pigeons. Hence this drug is an effective de-wormer in animals.
Published: 2024-01-16
Pages: 91
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now